References
- Andersen M. E. Saturable metabolism and its relationship to toxicity. Crit. Rev. Toxicol. 1981; 9: 105–150
- Andersen M. E. Tissue dosimetry in risk assessment: What's the problem here any way?. Drinking Water Health 1987; 8: 8–23
- Andersen M. E., Mills J. J., Jirtle R. L., Greenlee W. F. Negative selection in hepatic tumor promotion in relation to cancer risk assessment. Toxicology 1995, in press
- D'Souza R. W., Andersen M. E. Physiologically-based pharmacokinetic model for vinylidene chloride. Toxicol. Appl. Pharmacol. 1988; 95: 230–240
- Gehring P. J., Watanabe P. C., Young J. D. The relevance of dose-dependent pharmacokinetics in the assessment of carcinogenic hazard of chemicals. Origins of human cancer, Book A: Incidence of cancer in humans (Cold Spring Harbor Conferences on Cell Proliferation, Vol. 4), H. H. Hiatt, J. D. Watson, J. A. Winsten. Cold Spring Harbor Laboratory, Cold Spring-Harbor, NY 1977; 187–203
- Gehring P. J., Watanabe P. C., Park C. N. Resolution of dose-response toxicity data for chemicals requiring metabolic activation: Example—Vinyl chloride. Toxicol. Appl. Pharmacol. 1978; 44: 581–591
- Jirtle R. L., Meyer S. A., Brockenbrough J. S. Liver tumor promoter phenobarbital: A biphasic modulator of hepatocyte proliferation. Chemically induced cell proliferation: Implications for risk assessment, B. Butterworth, T. Slaga, W. Farland, M. McClain. Wiley-Liss, New York 1991; 209–216
- Maltoni C. The value of predictive experimental bioassays in occupational and environmental carcinogeneses. An example: Vinyl chloride. Ambio 1975; 4: 18–23
- Mehendale H. Potentiation of halomethane hepatotoxicity by chlordecone: A hypothesis for the mechanism. Med. Hypoth. 1990; 33: 289–299
- Mills J. J., Andersen M. E. Dioxin hepatic carcinogensis: Biologically motivated modeling and risk assessment. Toxicol. Lett. 1993; 68: 177–189
- Pitot H. C., Goldsworthy T. L., Moran S., Kennan W., Glauert H. R., Maronpot R. R., Campbell H. A. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose response relationships to hepatic foci. Carcinogenesis 1987; 8: 1491–1499
- Watanabe P. H., McGowan C. R., Madrid E. O., Gehring P. J. Fate of 14C-vinyl chloride following Inhalation exposure in rats. Toxicol. Appl. Pharmacol. 1976; 37: 49–59